Timing of HCG Administration in IUI Cycles

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

225 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2019-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Intrauterine Injection of Hcg Before ET on Clinical Outcomes in IVF/ICSI Cycles

NCT03238807

Infertility ART

COMPLETED NA

Intra-uterine Injection of Human Chorionic Gonadotrophin (hCG) Before Embryo Transfer

NCT01030393

Infertility

COMPLETED PHASE4

Timing and Intrauterine Insemination in Unexplained Infertility

NCT03920514

Intrauterine Insemination

UNKNOWN PHASE4

HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

NCT05969834

Infertility

COMPLETED

Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI

NCT03445910

Repeated Implantation Failure

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women will be randomly divided into 3 groups; the first group will undergo IUI at the time HCG administration, the second group will undergo IUI 12 hours after HCG administration and the third group will undergo IUI 34-36 hours after HCG administration.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

IUI at time of HCG

Group Type ACTIVE_COMPARATOR

HCG

Intervention Type DRUG

Women will be given HCG before IUI

Group B

IUI 12 hours after HCG

Group Type ACTIVE_COMPARATOR

HCG

Intervention Type DRUG

Women will be given HCG before IUI

Group C

IUI 34-36 hours after HCG

Group Type ACTIVE_COMPARATOR

HCG

Intervention Type DRUG

Women will be given HCG before IUI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HCG

Women will be given HCG before IUI

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Pregnyl

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mild male factor infertility or unexplained infertility.

Exclusion Criteria

* Advanced male factor infertility.
* Polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria.
* Endometriosis.
* Tubal disease.
* Uterine abnormalities or myoma.
* Previous uterine surgery.
* Metabolic or hormonal abnormalities.

Minimum Eligible Age

20 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No